Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 342

1.

Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution.

Högerle BA, Lasitschka F, Muley T, Bougatf N, Herfarth K, Adeberg S, Eichhorn M, Debus J, Winter H, Rieken S, Uhl M.

Radiat Oncol. 2019 Jul 4;14(1):117. doi: 10.1186/s13014-019-1323-z.

2.

Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients-First Clinical Results From a Single Center.

König L, Lang K, Heil J, Golatta M, Major G, Krug D, Hörner-Rieber J, Häfner MF, Koerber SA, Harrabi S, Bostel T, Debus J, Uhl M.

Front Oncol. 2019 May 21;9:384. doi: 10.3389/fonc.2019.00384. eCollection 2019.

3.

Preoperative selective embolization with vascular coiling of giant sacrococcygeal teratoma.

Stavropoulou D, Hentschel R, Rädecke J, Kunze M, Niemeyer C, Uhl M, Grohmann J.

J Neonatal Perinatal Med. 2019 Mar 29. doi: 10.3233/NPM-180066. [Epub ahead of print]

PMID:
30932896
4.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society.

Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14.

PMID:
30782343
5.

A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.

Vogin G, Wambersie A, Koto M, Ohno T, Uhl M, Fossati P, Balosso J; ULICE WP2 working group.

Radiat Oncol. 2019 Feb 1;14(1):24. doi: 10.1186/s13014-019-1224-1.

6.

Wire-frame integrity of patch-like Gore devices following atrial septal defect closure.

Kubicki R, Fingerhut K, Uhl M, Hummel J, Höhn R, Reineker K, Fleck T, Stiller B, Grohmann J.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):E238-E243. doi: 10.1002/ccd.28103. Epub 2019 Jan 24.

PMID:
30680882
7.

Glycerol confined in zeolitic imidazolate frameworks: The temperature-dependent cooperativity length scale of glassy freezing.

Uhl M, Fischer JKH, Sippel P, Bunzen H, Lunkenheimer P, Volkmer D, Loidl A.

J Chem Phys. 2019 Jan 14;150(2):024504. doi: 10.1063/1.5080334.

PMID:
30646699
8.

Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety.

Akbaba S, Lang K, Held T, Bulut OC, Mattke M, Uhl M, Jensen A, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2018 Oct 18;10(10). pii: E388. doi: 10.3390/cancers10100388.

9.

Intraoperative Electron Radiation Therapy Combined with External Beam Radiation Therapy after Gross Total Resection in Extremity Soft Tissue Sarcoma: A European Pooled Analysis.

Roeder F, de Paoli A, Saleh-Ebrahimi L, Alldinger I, Bertola G, Boz G, Navarria F, Cuervo M, Uhl M, Alvarez A, Buechler M, Lehner B, Debus J, Calvo FA, Krempien R.

Ann Surg Oncol. 2018 Dec;25(13):3833-3842. doi: 10.1245/s10434-018-6787-9. Epub 2018 Oct 1.

PMID:
30276647
10.

Force-dependent diffusion coefficient of molecular Brownian ratchets.

Uhl M, Seifert U.

Phys Rev E. 2018 Aug;98(2-1):022402. doi: 10.1103/PhysRevE.98.022402.

PMID:
30253613
11.

Sacral insufficiency fractures after high-dose carbon-ion based radiotherapy of sacral chordomas.

Bostel T, Nicolay NH, Welzel T, Bruckner T, Mattke M, Akbaba S, Sprave T, Debus J, Uhl M.

Radiat Oncol. 2018 Aug 23;13(1):154. doi: 10.1186/s13014-018-1095-x.

12.

Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.

Sprave T, Verma V, Sterzing F, Bruckner T, Hees K, Land B, Jäkel O, Herfarth K, Debus J, Uhl M.

Anticancer Res. 2018 Aug;38(8):4853-4858. doi: 10.21873/anticanres.12797.

PMID:
30061259
13.

Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.

Welzel T, Meyerhof E, Uhl M, Huang K, von Deimling A, Herfarth K, Debus J.

Eur J Radiol. 2018 Aug;105:119-124. doi: 10.1016/j.ejrad.2018.05.026. Epub 2018 May 29.

PMID:
30017267
14.

Clinical and radiographical ten years long-term outcome of microfracture vs. autologous chondrocyte implantation: a matched-pair analysis.

Ossendorff R, Franke K, Erdle B, Uhl M, Südkamp NP, Salzmann GM.

Int Orthop. 2019 Mar;43(3):553-559. doi: 10.1007/s00264-018-4025-5. Epub 2018 Jun 16.

PMID:
29909583
15.

Austrian reference values for phthalate metabolite exposure in children/adolescents and adults.

Hartmann C, Uhl M, Weiss S, Scharf S, König J.

Int J Hyg Environ Health. 2018 Jul;221(6):985-989. doi: 10.1016/j.ijheh.2018.06.001. Epub 2018 Jun 13.

PMID:
29908910
16.

Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.

Zhang Y, Pitchiaya S, Cieślik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S, Subramaniam S, Shukla SK, Jiang X, Wang L, Liu TY, Uhl M, Gawronski AR, Qiao Y, Xiao L, Dhanasekaran SM, Juckette KM, Kunju LP, Cao X, Patel U, Batish M, Shukla GC, Paulsen MT, Ljungman M, Jiang H, Mehra R, Backofen R, Sahinalp CS, Freier SM, Watt AT, Guo S, Wei JT, Feng FY, Malik R, Chinnaiyan AM.

Nat Genet. 2018 Jun;50(6):814-824. doi: 10.1038/s41588-018-0120-1. Epub 2018 May 28.

17.

Determination of hydroxy metabolites of cocaine from hair samples and comparison with street cocaine samples.

Franz T, Scheufler F, Stein K, Uhl M, Dame T, Schwarz G, Sachs H, Skopp G, Musshoff F.

Forensic Sci Int. 2018 Jul;288:223-226. doi: 10.1016/j.forsciint.2018.04.007. Epub 2018 Apr 12.

PMID:
29775923
18.

Functionally separated networks for self-paced and externally-cued motor execution in Parkinson's disease: Evidence from deep brain recordings in humans.

Bichsel O, Gassert R, Stieglitz L, Uhl M, Baumann-Vogel H, Waldvogel D, Baumann CR, Imbach LL.

Neuroimage. 2018 Aug 15;177:20-29. doi: 10.1016/j.neuroimage.2018.05.012. Epub 2018 May 5.

PMID:
29738912
19.

MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactions.

Gawronski AR, Uhl M, Zhang Y, Lin YY, Niknafs YS, Ramnarine VR, Malik R, Feng F, Chinnaiyan AM, Collins CC, Sahinalp SC, Backofen R.

Bioinformatics. 2018 Sep 15;34(18):3101-3110. doi: 10.1093/bioinformatics/bty208.

20.

hnRNP R and its main interactor, the noncoding RNA 7SK, coregulate the axonal transcriptome of motoneurons.

Briese M, Saal-Bauernschubert L, Ji C, Moradi M, Ghanawi H, Uhl M, Appenzeller S, Backofen R, Sendtner M.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2859-E2868. doi: 10.1073/pnas.1721670115. Epub 2018 Mar 5.

21.

High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.

Mattke M, Vogt K, Bougatf N, Welzel T, Oelmann-Avendano J, Hauswald H, Jensen A, Ellerbrock M, Jäkel O, Haberer T, Herfarth K, Debus J, Uhl M.

Cancer. 2018 May 1;124(9):2036-2044. doi: 10.1002/cncr.31298. Epub 2018 Feb 22.

22.

Long-Term Clinical and MRI Results of Matrix-Assisted Autologous Chondrocyte Implantation for Articular Cartilage Defects of the Knee.

Kreuz PC, Kalkreuth RH, Niemeyer P, Uhl M, Erggelet C.

Cartilage. 2019 Jul;10(3):305-313. doi: 10.1177/1947603518756463. Epub 2018 Feb 11.

PMID:
29429373
23.

Intraoperative Electron Radiation Therapy in Retroperitoneal Sarcoma.

Roeder F, Alldinger I, Uhl M, Saleh-Ebrahimi L, Schimmack S, Mechtersheimer G, Büchler MW, Debus J, Krempien R, Ulrich A.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):516-527. doi: 10.1016/j.ijrobp.2017.10.034. Epub 2017 Oct 31.

PMID:
29353660
24.

Patient-perceived barriers and facilitators to the implementation of a medication review in primary care: a qualitative thematic analysis.

Uhl MC, Muth C, Gerlach FM, Schoch GG, Müller BS.

BMC Fam Pract. 2018 Jan 5;19(1):3. doi: 10.1186/s12875-017-0707-0.

25.

Therapeutic options and postoperative wound complications after extremity soft tissue sarcoma resection and postoperative external beam radiotherapy.

Abouarab MH, Salem IL, Degheidy MM, Henn D, Hirche C, Eweida A, Uhl M, Kneser U, Kremer T.

Int Wound J. 2018 Feb;15(1):148-158. doi: 10.1111/iwj.12851. Epub 2017 Dec 5. Review.

PMID:
29205902
26.

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.

Schäfer N, Proescholdt M, Steinbach JP, Weyerbrock A, Hau P, Grauer O, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Grau S, Hänel M, Schnell O, Krex D, Vajkoczy P, Tabatabai G, Mack F, Schaub C, Tzaridis T, Nießen M, Kebir S, Leutgeb B, Urbach H, Belka C, Stummer W, Glas M, Herrlinger U.

Neuro Oncol. 2018 Jun 18;20(7):975-985. doi: 10.1093/neuonc/nox204.

27.

Sequential proton boost after standard chemoradiation for high-grade glioma.

Adeberg S, Bernhardt D, Harrabi SB, Uhl M, Paul A, Bougatf N, Verma V, Unterberg A, Wick W, Haberer T, Combs SE, Herfarth K, Debus J, Rieken S.

Radiother Oncol. 2017 Nov;125(2):266-272. doi: 10.1016/j.radonc.2017.09.040. Epub 2017 Oct 16.

PMID:
29050959
28.

Sporting Activity Is Reduced 11 Years After First-Generation Autologous Chondrocyte Implantation in the Knee Joint.

Erdle B, Herrmann S, Porichis S, Uhl M, Ghanem N, Schmal H, Suedkamp N, Niemeyer P, Salzmann GM.

Am J Sports Med. 2017 Oct;45(12):2762-2773. doi: 10.1177/0363546517716920. Epub 2017 Aug 8.

PMID:
28787185
29.

RIP-Seq Suggests Translational Regulation by L7Ae in Archaea.

Daume M, Uhl M, Backofen R, Randau L.

MBio. 2017 Aug 1;8(4). pii: e00730-17. doi: 10.1128/mBio.00730-17.

30.

Spot on for liars! How public scrutiny influences ethical behavior.

Ostermaier A, Uhl M.

PLoS One. 2017 Jul 17;12(7):e0181682. doi: 10.1371/journal.pone.0181682. eCollection 2017.

31.

Treatment of a Focal Articular Cartilage Defect of the Talus with Polymer-Based Autologous Chondrocyte Implantation: A 12-Year Follow-Up Period.

Kreuz PC, Kalkreuth RH, Niemeyer P, Uhl M, Erggelet C.

J Foot Ankle Surg. 2017 Jul - Aug;56(4):862-864. doi: 10.1053/j.jfas.2017.03.001.

PMID:
28633793
32.

A Case Report of Severe Delirium after Amantadine Withdrawal.

Marxreiter F, Winkler J, Uhl M, Madžar D.

Case Rep Neurol. 2017 Mar 20;9(1):44-48. doi: 10.1159/000460814. eCollection 2017 Jan-Apr.

33.

Computational analysis of CLIP-seq data.

Uhl M, Houwaart T, Corrado G, Wright PR, Backofen R.

Methods. 2017 Apr 15;118-119:60-72. doi: 10.1016/j.ymeth.2017.02.006. Epub 2017 Feb 22. Review.

PMID:
28254606
34.

Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1).

Lienhart WD, Strandback E, Gudipati V, Koch K, Binter A, Uhl MK, Rantasa DM, Bourgeois B, Madl T, Zangger K, Gruber K, Macheroux P.

FEBS J. 2017 Apr;284(8):1233-1245. doi: 10.1111/febs.14051. Epub 2017 Mar 17.

35.

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.

Stacchiotti S, Gronchi A, Fossati P, Akiyama T, Alapetite C, Baumann M, Blay JY, Bolle S, Boriani S, Bruzzi P, Capanna R, Caraceni A, Casadei R, Colia V, Debus J, Delaney T, Desai A, Dileo P, Dijkstra S, Doglietto F, Flanagan A, Froelich S, Gardner PA, Gelderblom H, Gokaslan ZL, Haas R, Heery C, Hindi N, Hohenberger P, Hornicek F, Imai R, Jeys L, Jones RL, Kasper B, Kawai A, Krengli M, Leithner A, Logowska I, Martin Broto J, Mazzatenta D, Morosi C, Nicolai P, Norum OJ, Patel S, Penel N, Picci P, Pilotti S, Radaelli S, Ricchini F, Rutkowski P, Scheipl S, Sen C, Tamborini E, Thornton KA, Timmermann B, Torri V, Tunn PU, Uhl M, Yamada Y, Weber DC, Vanel D, Varga PP, Vleggeert-Lankamp CLA, Casali PG, Sommer J.

Ann Oncol. 2017 Jun 1;28(6):1230-1242. doi: 10.1093/annonc/mdx054. Review.

36.

Mechanism of β-actin mRNA Recognition by ZBP1.

Nicastro G, Candel AM, Uhl M, Oregioni A, Hollingworth D, Backofen R, Martin SR, Ramos A.

Cell Rep. 2017 Jan 31;18(5):1187-1199. doi: 10.1016/j.celrep.2016.12.091.

37.

Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials.

Merkel A, Soeldner D, Wendl C, Urkan D, Kuramatsu JB, Seliger C, Proescholdt M, Eyupoglu IY, Hau P, Uhl M.

J Neurooncol. 2017 Apr;132(2):249-254. doi: 10.1007/s11060-016-2362-z. Epub 2017 Jan 18.

38.

From Röntgen Rays to Carbon Ion Therapy: The Evolution of Modern Radiation Oncology in Germany.

Lischalk JW, König L, Repka MC, Uhl M, Dritschilo A, Herfarth K, Debus J.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):729-735. doi: 10.1016/j.ijrobp.2016.08.026. Epub 2016 Aug 30. No abstract available.

40.

The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.

Niknafs YS, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, Prensner JR, Poliakov A, Singhal U, Xiao L, Kregel S, Siebenaler RF, Zhao SG, Uhl M, Gawronski A, Hayes DF, Pierce LJ, Cao X, Collins C, Backofen R, Sahinalp CS, Rae JM, Chinnaiyan AM, Feng FY.

Nat Commun. 2016 Sep 26;7:12791. doi: 10.1038/ncomms12791.

41.

Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?

Jensen AD, Poulakis M, Vanoni V, Uhl M, Chaudhri N, Federspil PA, Freier K, Krauss J, Debus J.

Radiat Oncol. 2016 Jul 7;11(1):90. doi: 10.1186/s13014-016-0657-z.

42.

[Stress fractures].

Uhl M.

Radiologe. 2016 Jul;56(7):631-44. doi: 10.1007/s00117-016-0104-z. Review. German.

PMID:
27271805
43.

[Cartilage tumors : Pathology and radiomorphology].

Uhl M, Herget G, Kurz P.

Radiologe. 2016 Jun;56(6):476-88. doi: 10.1007/s00117-016-0112-z. Review. German.

PMID:
27233920
44.

[Bone tumors : Radiologic-pathologic correlation].

Uhl M, Delorme S.

Radiologe. 2016 Jun;56(6):474-5. doi: 10.1007/s00117-016-0114-x. German. No abstract available.

PMID:
27233919
45.

Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

Seliger C, Meyer AL, Renner K, Leidgens V, Moeckel S, Jachnik B, Dettmer K, Tischler U, Gerthofer V, Rauer L, Uhl M, Proescholdt M, Bogdahn U, Riemenschneider MJ, Oefner PJ, Kreutz M, Vollmann-Zwerenz A, Hau P.

Cell Cycle. 2016 Jul 2;15(13):1755-66. doi: 10.1080/15384101.2016.1186316. Epub 2016 May 10.

46.

Development of a simplified urban water balance model (WABILA).

Henrichs M, Langner J, Uhl M.

Water Sci Technol. 2016;73(8):1785-95. doi: 10.2166/wst.2016.020.

PMID:
27120631
47.

Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.

Habl G, Uhl M, Katayama S, Kessel KA, Hatiboglu G, Hadaschik B, Edler L, Tichy D, Ellerbrock M, Haberer T, Wolf MB, Schlemmer HP, Debus J, Herfarth K.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):435-43. doi: 10.1016/j.ijrobp.2016.02.025. Epub 2016 Feb 12.

PMID:
27084659
48.

Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow-up.

Herget GW, Mauer D, Krauß T, El Tayeh A, Uhl M, Südkamp NP, Hauschild O.

BMC Musculoskelet Disord. 2016 Apr 5;17:147. doi: 10.1186/s12891-016-1004-0.

49.

Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).

Arians N, Foerster R, Rom J, Uhl M, Roeder F, Debus J, Lindel K.

Radiat Oncol. 2016 Mar 18;11:44. doi: 10.1186/s13014-016-0622-x.

50.

Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma.

Proske J, Walter L, Bumes E, Hutterer M, Vollmann-Zwerenz A, Eyüpoglu IY, Savaskan NE, Seliger C, Hau P, Uhl M.

Anticancer Res. 2016 Mar;36(3):899-905.

PMID:
26976976

Supplemental Content

Support Center